Prof. Zhiliang Gao, Third Affiliated Hospital of Sun Yat-Sen University, China
Dr. Zhiliang Gao is a distinguished expert in infectious diseases with numerous prestigious roles and honors. He leads China’s National Excellence Courses and has received the “Special Government Allowance” and “Baosteel Outstanding Teacher Award.”📚 As Chief Physician and PhD supervisor at Sun Yat-sen University, he directs the Department of Infectious Diseases and the Emergency Treatment Center for Infectious Diseases. 🏥 Dr. Gao has received multiple accolades, including the Guangdong Science and Technology Award. 🏆 He actively contributes to national health initiatives and has published influential research in top journals like Cell and Hepatology. 📖
Publication profile
Scopus
Awards and Achievements 🏆
Dr. Zhiliang Gao is a trailblazer in medical education and infectious diseases. He leads China’s National Excellence Courses and has earned the “Special Government Allowance” from the State Council. 🏅 He’s been honored as the “Baosteel Outstanding Teacher” and “Famous Doctor of the Nation.” Dr. Gao has received the Guangdong Teaching Achievement Award twice and the First Prize of Guangdong Science and Technology Award. 📜 He is the editor-in-chief of the English edition of Infectious Diseases and has published pivotal research in top journals like Cell and Hepatology. 📚
Research Focus
Dr. Zhiliang Gao’s research primarily focuses on infectious diseases, with a particular emphasis on chronic hepatitis B (CHB) and its therapeutic strategies. 🦠 His work is instrumental in advancing clinical approaches towards the functional cure of CHB, as evidenced by his involvement in national programs and key publications in prominent journals. 📘 Dr. Gao’s research also explores the role of antiviral therapies and immune modulation in hepatitis B management. Additionally, he investigates the effects of drugs like tenofovir and dopamine on viral antigen expression and liver disease outcomes, contributing significantly to the field of hepatology and viral infections. 🔬
Publication Top Notes
- Therapeutic strategies, practice, and prospect of a clinical cure for chronic hepatitis B in China (2024, 0 citations) 📝
- Mo, Z.S., Xie, D.Y., Lin, B.L., Zhuang, H., Gao, Z.L., Chinese Journal of Hepatology
- Dopamine Inhibits the Expression of Hepatitis B Virus Surface and e Antigens by Activating the JAK/STAT Pathway and Upregulating Interferon-stimulated Gene 15 Expression (2024, 0 citations) 🧬
- Liu, X., Pang, X., Wan, Z., Gao, Z., Deng, H., Journal of Clinical and Translational Hepatology
- Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium (2023, 6 citations) 🌍
- Bajaj, J.S., Choudhury, A.K., Xie, Q., Duarte Rojo, A., Cabello Negrillo, R., The Lancet Gastroenterology and Hepatology
- Expert Consensus on the Prevention and Treatment of Hemorrhagic Fever with Renal Syndrome (2022, 4 citations) 🦠
- Jiang, H., Huang, C., Bai, X., Wang, G., Gao, Z., Medicine (United States)
- Randomised clinical trial: 48 weeks of treatment with tenofovir amibufenamide versus tenofovir disoproxil fumarate for patients with chronic hepatitis B (2021, 18 citations) 💊
- Liu, Z., Jin, Q., Zhang, Y., Niu, J., Hou, J., Alimentary Pharmacology and Therapeutics
- Association of central obesity with hepatocellular carcinoma in patients with chronic hepatitis B receiving antiviral therapy (2021, 16 citations) ⚖️
- Fan, R., Niu, J., Ma, H., Wang, G., Jiang, Y., Alimentary Pharmacology and Therapeutics
- Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks (2021, 0 citations) 📊
- Chen, X.-F., Fan, Y.-N., Si, C.-W., Wang, L., Dai, J., World Journal of Clinical Cases
- Plasma Interleukin-6 Level: A Potential Prognostic Indicator of Emergent HBV-Associated ACLF (2021, 17 citations) 🔬
- Wu, Z.-B., Zheng, Y.-B., Wang, K., Yan, Y., Gao, Z.-L., Canadian Journal of Gastroenterology and Hepatology
- Translation: Expert Consensus on the Application of Artificial Liver Blood Purification System in the Treatment of Severe and Critical COVID-19 (2020, 1 citation) 🏥
- Chen, L., Chen, Y., Chen, Y., Zhang, Y., Chen, J., Infectious Microbes and Diseases
- Functional cure of chronic hepatitis B: Efforts and prospects (2020, 5 citations) 🌟
- Mo, Z., Gan, W., Zhao, Q., Yin, Y., Gao, Z., Liver Research